ArticleCancer research2021

A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.

Salah Boudjadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.